Pharmagest Interactive: H2 2020 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT

Villers-lès-Nancy, 29 January 2021 – 06:00 p.m. (CET)

PRESS RELEASE
For immediate release

H2 2020 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT
WITH THE BROKERAGE FIRM GILBERT DUPONT

Under the liquidity agreement administered by the brokerage firm, Gilbert Dupont, on behalf of PHARMAGEST INTERACTIVE, liquidity account holdings at 31 December 2020 were as follows:

- Number of shares: 1,699
- Cash balance: €283,863.20

For the 2020 second half, a summary of total transactions is provided below:

PURCHASES	41,743 shares	€3,763,681.39	1,984 transactions
SALES	41,843 shares	€3,798,700.90	2,223 transactions

For information, liquidity account holdings were reported as follows:
in the half-year report of 30 June 2020:

- Number of shares: 1,799
- Cash balance: €248,843.67

when the liquidity agreement was first implemented:

- Number of shares: 2,219
- Cash balance: €50,000.00

This liquidity agreement is executed in accordance with decision No. 2018-01 of 2 July 2018 of the Autorité des Marchés Financiers (“AMF”) establishing accepted market practices in relation to liquidity agreements for shares.

About Pharmagest Group:

With more than 1,100 employees acting as “Citizens in the Service of Health and Well-Being”, Pharmagest Group is the leading provider of IT solutions for the healthcare sector in Europe through innovative solutions and services for healthcare professionals guaranteeing the efficiency of the healthcare system and improving the patient care pathway.

As a key contributor to the quality of healthcare and coordination between office-based private practice and hospitals, Pharmagest Group is present in France, Italy, Belgium, Luxembourg and the United Kingdom where it is developing the leading healthcare platform and a single ecosystem for France and Europe bringing the best of technology to the service of people.

Listed on Euronext Paris™ - Compartment B
Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2019 - CAC^® SMALL and CAC^® All-Tradable

Included under the European Rising Tech label.

Eligible for the “long-only” Deferred Settlement Service (“Service à Réglement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME).
ISIN: FR 0012882389 – Reuters: PHA.PA – Bloomberg: - PMGI FP

For all the latest news go to www.pharmagest.com

Follow Pharmagest on Twitter: @Pharmagest, LinkedIn and Facebook

CONTACTS

Analyst and Investor Relations:
Chief Administrative and Financial Officer : Jean-Yves Samson
Tel. +33 (0)3 83 15 90 67 - jean-yves.samson@lacooperativewelcoop.com

Media Relations:
FIN’EXTENSO - Isabelle APRILE

Tel. +33 (0)3 39 97 61 22 - i.aprile@finextenso.fr

APPENDIX

	Purchases			Sales
	Number of transactions	Number of shares	Amounts in EUR	Number of transactions	Number of shares	Amounts in EUR
TOTAL	1,984	41,743	3,763,681.39	2,223	41,843	3,798,700.90
01/07/2020	21	257	19649.09	3	65	5011.5
02/07/2020	5	45	3438.3	18	275	21066.9
03/07/2020	6	110	8406.6	11	135	10407
06/07/2020	0	0	0	10	243	19585.51
07/07/2020	0	0	0	4	89	7340
08/07/2020	4	66	5280	0	0	0
09/07/2020	0	0	0	8	122	10248
10/07/2020	0	0	0	0	0	0
13/07/2020	0	0	0	4	38	3157
14/07/2020	0	0	0	0	0	0
15/07/2020	0	0	0	0	0	0
16/07/2020	0	0	0	0	0	0
17/07/2020	0	0	0	0	0	0
20/07/2020	0	0	0	0	0	0
21/07/2020	0	0	0	0	0	0
22/07/2020	0	0	0	0	0	0
23/07/2020	0	0	0	0	0	0
24/07/2020	0	0	0	0	0	0
27/07/2020	0	0	0	0	0	0
28/07/2020	0	0	0	0	0	0
29/07/2020	0	0	0	0	0	0
30/07/2020	7	104	8320	4	20	1620
31/07/2020	1	25	2000	4	24	1961.8
03/08/2020	2	100	8000	4	51	4167.8
04/08/2020	0	0	0	1	23	1906.7
05/08/2020	0	0	0	0	0	0
06/08/2020	0	0	0	1	61	5124
07/08/2020	0	0	0	0	0	0
10/08/2020	0	0	0	0	0	0
11/08/2020	0	0	0	0	0	0
12/08/2020	0	0	0	0	0	0
13/08/2020	0	0	0	0	0	0
14/08/2020	0	0	0	0	0	0
17/08/2020	0	0	0	0	0	0
18/08/2020	0	0	0	0	0	0
19/08/2020	0	0	0	0	0	0
20/08/2020	0	0	0	0	0	0
21/08/2020	0	0	0	0	0	0
24/08/2020	0	0	0	0	0	0
25/08/2020	0	0	0	0	0	0
26/08/2020	0	0	0	0	0	0
27/08/2020	0	0	0	0	0	0
28/08/2020	0	0	0	0	0	0
31/08/2020	59	1330	103672.17	10	345	27390
01/09/2020	26	480	38091.79	6	93	7460.4
02/09/2020	19	432	34272.98	25	221	17553.7
03/09/2020	34	796	62608.66	26	476	37678.59
04/09/2020	21	775	59273.01	51	1029	79552.92
07/09/2020	19	349	27331.52	23	409	32261.51
08/09/2020	32	682	53640.12	10	110	8740.8
09/09/2020	36	436	33604.39	0	0	0
10/09/2020	11	180	13807.01	39	904	70300.37
11/09/2020	33	370	28953.31	20	343	26976.61
14/09/2020	6	154	11874.2	27	513	40092.59
15/09/2020	11	238	18735.1	26	494	39128.01
16/09/2020	0	0	0	7	53	4218.8
17/09/2020	17	230	18244.59	4	74	5886
18/09/2020	0	0	0	29	543	43341.83
21/09/2020	27	490	38996.01	3	112	9296
22/09/2020	1	35	2712.5	56	665	52908
23/09/2020	9	182	14551.99	1	7	573.3
24/09/2020	19	425	33021.48	13	290	22595.99
25/09/2020	25	250	19534.8	52	578	45661.31
28/09/2020	19	206	16396.41	26	385	31016.22
29/09/2020	7	200	16440	15	259	21541.99
30/09/2020	29	404	33416.9	9	236	20025
01/10/2020	19	431	35299.5	14	132	10825.4
02/10/2020	19	329	26904.21	21	207	16958.99
05/10/2020	0	0	0	40	668	56522.62
06/10/2020	49	1066	91345.33	15	200	17323.9
07/10/2020	0	0	0	50	1076	93661.82
08/10/2020	60	1196	104802.25	19	310	27517
09/10/2020	30	720	62316.29	12	190	16596.01
12/10/2020	15	400	34423	21	470	40624.5
13/10/2020	23	1040	88323.04	40	1072	91579.35
14/10/2020	12	215	18783.99	23	837	73488.18
15/10/2020	53	740	64002.01	4	74	6401.6
16/10/2020	11	328	28521.99	29	842	73618.59
19/10/2020	8	225	20088.99	48	670	60386.03
20/10/2020	55	891	81312.39	27	367	33817.29
21/10/2020	23	450	40733.6	34	533	48485.89
22/10/2020	15	248	22588.81	28	651	59692.79
23/10/2020	36	851	78541.77	42	776	71903.07
26/10/2020	22	783	71901.09	40	880	81034.18
27/10/2020	20	426	39029.01	19	460	42189.59
28/10/2020	75	1417	124868.45	0	0	0
29/10/2020	12	434	36266.08	24	398	33525.81
30/10/2020	5	100	8605	30	730	63037.47
02/11/2020	41	530	46371.98	13	164	14353.39
03/11/2020	0	13	1134.9	0	456	40034.52
04/11/2020	9	122	10861.79	31	694	61880.93
05/11/2020	9	272	24696.4	30	604	54987.37
06/11/2020	40	1136	102182.63	6	170	15364.01
09/11/2020	80	1425	126318.56	42	860	78108.47
10/11/2020	49	786	67615.49	7	160	13999.01
11/11/2020	13	153	13163.29	48	839	72827.63
12/11/2020	26	469	41032.39	34	550	48623.03
13/11/2020	22	428	37957.61	49	781	69810.93
16/11/2020	49	873	75359.72	23	333	30011.89
17/11/2020	11	235	20280.99	5	150	13045.01
18/11/2020	0	0	0	22	493	43336.18
19/11/2020	4	114	10344	56	855	80556.48
20/11/2020	16	397	37840.61	6	123	11773.81
23/11/2020	3	130	12770	32	594	58336.32
24/11/2020	23	661	65151.4	16	367	36425.12
25/11/2020	30	608	59549.89	16	238	23516.99
26/11/2020	12	255	24719.5	18	300	29157.09
27/11/2020	14	425	41223	3	115	11165.01
30/11/2020	18	209	20247.69	34	765	74491.88
01/12/2020	17	625	61380	48	850	83663.97
02/12/2020	18	377	37075.39	32	443	43614.41
03/12/2020	27	1017	99651.15	43	889	87293.31
04/12/2020	36	941	91910.76	31	588	57486.88
07/12/2020	50	847	81758.2	0	0	0
08/12/2020	40	722	68517.01	19	565	53519
09/12/2020	1	50	4785	76	1699	164784.14
10/12/2020	35	603	59399.72	16	214	21316.3
11/12/2020	39	817	79677.52	27	600	58608
14/12/2020	0	110	10762	0	443	43555.18
15/12/2020	2	50	4915	46	590	58847.78
16/12/2020	10	225	22903	26	351	35919.8
17/12/2020	1	16	1644.8	13	181	18788.2
18/12/2020	4	150	15642	6	62	6490
21/12/2020	0	628	65326.82	0	564	58777.99
22/12/2020	0	0	0	41	769	82014.23
23/12/2020	23	460	50880	27	420	46673.59
24/12/2020	31	466	51726.79	15	284	31583.41
25/12/2020	0	0	0	0	0	0
28/12/2020	31	694	76926.22	20	384	42723.61
29/12/2020	43	1180	130430	19	276	30738.2
30/12/2020	31	733	80168.43	38	316	34597.8
31/12/2020	8	150	16450.01	59	916	100913.8

Attachment

• PHARMAGEST_H2 2020 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT-PR-01292021